Eculizumab for transplant-associated thrombotic microangiopathy in adult allogeneic stem cell transplant recipients.
Joslyn RudoniAnna JanChitra HosingFleur AungJason C YehPublished in: European journal of haematology (2018)
Early initiation of ECU may not alter the disease process enough to restore organ function, but it may prolong survival.